Notice of Proposed Sale · 144

Hinge Health, Inc.

HNGENYSEEQUITYCurrent

Notice of Proposed Sale

Filed Sep 30, 2026Accepted Sep 30, 2026, 6:31 PM EDTFiling CIK 1710959Accession 0001974078-26-000370

View company →Permanent SEC source ↗

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer: Hinge Health, Inc.
Issuer CIK: 0001673743
SEC file number: 001-42657
Phone: 415-689-8429
Person for whose account securities are to be sold: Insight Venture Partners X, L.P.
Relationships to issuer: 10% Stockholder
Street: 455 MARKET STREET
Street (continued): 7TH FLOOR
City: SAN FRANCISCO
State / country code: CA
Postal code: 94105

Securities proposed for sale

Securities proposed for sale · 1 reported row
Security	Proposed units	Aggregate market value	Units outstanding	Approximate sale date	Exchange	Broker / market maker
Class A	486,991	47,725,118.00	62,468,721	09/30/2026	NYSE	Raymond James & Associates Inc.

Broker / market maker — proposed row 1, entry 1

Name: Raymond James & Associates Inc.
Street: 880 Carillon Parkway
City: St. Petersburg
State / country code: FL
Postal code: 33716

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
Security	Acquired	Nature of acquisition	Acquired from	Amount acquired	Gift transaction	Payment date	Nature of payment
Series B Preferred Stock	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.	106,729	N	07/03/2018	Wired to portfolio company

Sales reported in the preceding three months

Sales reported in the preceding three months · 6 reported rows
Seller	Security	Sale date	Amount sold	Gross proceeds
Insight Venture Partners X, L.P	Class A	07/07/2026	122,188	11,024,571.14
Insight Venture Partners X, L.P	Class A	07/09/2026	90,639	8,175,583.42
nsight Venture Partners X, L.P	Class A	07/13/2026	122,039	10,999,033.36
nsight Venture Partners X, L.P	Class A	07/14/2026	19,487	1,760,455.58
Insight Venture Partners X, L.P	Class A	08/07/2026	68,781	6,200,799.74
Insight Venture Partners X, L.P	Class A	08/10/2026	309,309	28,307,155.48

Seller — prior-sale row 1, entry 1

Name: Insight Venture Partners X, L.P
Street: 1114 Avenue of the Americas
Street (continued): 36th floor
City: New York
State / country code: NY
Postal code: 10036

Seller — prior-sale row 2, entry 1

Name: Insight Venture Partners X, L.P
Street: 1114 Avenue of the Americas
Street (continued): 36th floor
City: New York
State / country code: NY
Postal code: 10036

Seller — prior-sale row 3, entry 1

Name: nsight Venture Partners X, L.P
Street: 1114 Avenue of the Americas
Street (continued): 36th floor
City: New York
State / country code: NY
Postal code: 10036

Seller — prior-sale row 4, entry 1

Name: nsight Venture Partners X, L.P
Street: 1114 Avenue of the Americas
Street (continued): 36th floor
City: New York
State / country code: NY
Postal code: 10036

Seller — prior-sale row 5, entry 1

Name: Insight Venture Partners X, L.P
Street: 1114 Avenue of the Americas,
City: New York
State / country code: NY
Postal code: 10036

Seller — prior-sale row 6, entry 1

Name: Insight Venture Partners X, L.P
Street: 1114 Avenue of the Americas
Street (continued): 36th floor
City: New York
State / country code: NY
Postal code: 10036

Prior-sale reporting

Nothing to report for the preceding three months: N

Notice signature

Notice date: 09/30/2026
Signed: Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners X, L.P
Plan adoption dates: 08/20/2026

Company context

We are a leading technology platform for individuals seeking to treat and prevent joint and muscle pain. We leverage technology and AI to automate and scale a care plan designed and monitored by our care team, while delivering improved member outcomes, personalized member experiences, and cost reductions for our clients.

Current securities

HNGENYSE · EQUITY · Current

Free Registration